We confirmed that MASLD donor livers exhibited more severe structural disruption and cell death (Fig. 8a,b), along with significant upregulation of EMP1 expression using immunohistochemistry (Fig. 8c). This evidence concerns the gene EMP1 and metabolic dysfunction-associated steatotic liver disease.